Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 June, 2018 06:45 IST
Dr. Reddy's Laboratories announces senior leadership changes
Source: IRIS | 29 Mar, 2018, 11.12AM
Comments  |  Post Comment

Dr. Reddy's Laboratories today announced a change in the makeup of its senior leadership team.

Following a 15-year career with the company, Abhijit Mukherjee, Chief Operating Officer, will retire on March 31, 2018.

Mukherjee will be succeeded by Erez Israeli, former President & CEO of Enzymotec. Israeli will join Dr. Reddy's (Q,N,C,F)* on April 2, 2018, as Chief Operating Officer and Global Head of Generics & PSAI, based out of Hyderabad. He will report to Dr. Reddy's Co-Chairman & CEO, G.V. Prasad.

In a career spanning over 25 years, Israeli has held leadership positions that have contributed significantly to the performance of companies he worked for. Prior to Enzymotec, he completed 23 years with Teva Pharmaceuticals Limited, where he held several positions of responsibility including Vice President Marketing & Sales for North America, Vice President Asia Operations, President Teva API, Group Executive Vice President, Head of Global Quality, and President & CEO Growth Markets.

Speaking about the transition, G.V. Prasad said, "I would like to thank Abhijit for his valuable contribution to our company's growth journey over the past fifteen years. I extend a warm welcome to Erez Israeli. Erez is an accomplished leader with a proven track record of achievement. His knowledge and experience from leading pharmaceutical businesses of scale will be valuable for our future growth."

Shares of the company declined Rs 19.7, or 0.94%, to settle at  Rs 2,082.45.  The total volume of shares traded  was  18,522 at the BSE (Wednesday).

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Dr. Reddy's defends right to launch Buprenorphine and Naloxone Sublingual Film - 18-Jun-2018 12:40
Lupin, Nichi-Iko in pact for commercialisation of Etanercept in Japan - 18-Jun-2018 11:38
Yes Bank gets SEBI approval for offering custodial services - 18-Jun-2018 10:06
Fitch affirms at Axis Bank and ICICI Bank's issuer rating at BBB- - 15-Jun-2018 15:36
Fitch affirms at Axis Bank and ICICI Bank's issuer rating at BBB- - 15-Jun-2018 15:36
Dhunseri Petrochem to exit JV in Egypt with Indorama - 15-Jun-2018 15:22
NBCC bags orders worth Rs 4.80 bn in May 2018 - 15-Jun-2018 15:16
Jammu and Kashmir Bank to raise tier-I capital up to Rs 10 bn - 15-Jun-2018 11:26
Alembic Pharma receives EIR for formulation facility at Panelav - 15-Jun-2018 10:39
MERC reserves order on R-Infra's sale of Mumbai power biz to Adani - 15-Jun-2018 10:16
Dr. Reddy's receives nod for Buprenorphine, Naloxone Sublingual film - 15-Jun-2018 09:50
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer